23 hrs ago
The Victoria Advocate
Dietitians Dish: May is Digestive Diseases Awareness Month
Digestive diseases can include anything from irritable bowel syndrome, Crohn's disease, diverticular disease or celiac disease to peptic ulcers.
Biomarkers discovered for inflammatory bowel disease
Using the Department of Defense Serum Repository , University of Cincinnati researchers have identified a number of biomarkers for inflammatory bowel disease , which could help with earlier diagnosis and intervention in those who have not yet shown symptoms.
Allergy Test For Crohn's Drug Before Treatment May Be Possible
A new study from researchers in Denmark may lead to a method of determining how patients with inflammatory bowel diseases will react to a certain drug, before the treatment is administered.
Mon May 20, 2013
Mayo Clinic: Inflammatory bowel disease raises risk of melanoma
Patients with inflammatory bowel disease are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic.
Sun May 19, 2013
The New Zealand Herald
Improvements for Kiwis who suffer from a painful disease
It is World Inflammatory Bowel Disease Day, and the plight of the estimated one in 35 New Zealanders who have Crohns Disease and Ulcerative Colitis is being highlighted.
Arthritis Drug Simponi (Golimumab) Gets Expanded Indication for Ulcerative Colitis
The FDA has approved a new use for Simponi injection to treat adults with moderate-to-severe ulcerative colitis.
Fri May 17, 2013
Santarus Announces UCERIS (budesonide) Poster Presentations at Digestive Disease Week Meeting
Santarus, Inc. today announced that additional data from two pivotal clinical studies with UCERIS extended release tablets will be featured in two poster presentations at the Digestive Disease Week Meeting being held in Orlando, Fla.
Thu May 16, 2013
SIMPONI (GOLIMUMAB) Receives FDA Approval for Ulcerative Colitis
First and Only Subcutaneous Biologic Treatment Approved to Induce and Maintain Clinical Response and Improve Endoscopic Appearance of the Mucosa During Induction Horsham, PA, - Janssen Biotech, Inc.
Wed May 15, 2013
Simponi Approved for Ulcerative Colitis
Simponi injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.
UPDATE 1-U.S. FDA approves J&J's Simponi to treat ulcerative colitis
The U.S. Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon.
Hershey experts to present on IBD
In an effort to help patients living with inflammatory bowel disease , Crohn's disease, and ulcerative colitis in central Pennsylvania, Penn State Hershey Inflammatory Bowel Disease Center experts, led by Dr.
Mon May 13, 2013
Frommer Lawrence & Haug Wins Lialda Verdict for Shire
The court also denied Actavis' counterclaim and found that the Shire patent was valid.
Sun May 12, 2013
Risk of venous thromboembolism in patients with IBD
This month's issue of the Alimentary Pharmacology & Therapeutics reviews the risk of venous thromboembolism in patients with inflammatory bowel disease.
Fri May 10, 2013
Sacramento Bee Newspaper
Actavis, Warner Chilcott discussing combination
The drugmakers Actavis Inc. and Warner Chilcott PLC say they are holding early discussions about a possible combination of the two companies.
Market overview: Shire jumps after winning trial over drug patent
0843: Markets like what BT had to say this morning. Yes, its 'top-line', or sales only beat consensus estimates mildly.
Thu May 09, 2013
Applied Clinical Trials
Shire Wins Patent Trial Against Watson Concerning LIALDA?
Shire plc , announces that its subsidiary, Shire Development LLC, has prevailed in its litigation against Watson Pharmaceuticals Inc., Watson Laboratories, Inc.- ", now "Actavis") in connection with their Abbreviated New Drug Application for a generic version of Shire's LIALDA delayed release tablets for the induction of remission in adults with ... (more)
Wed May 08, 2013
Four development-stage drug companies report earnings
Harlan F. Weisman is CEO of Coronado Biosciences Inc., which saw its stock decline 10 percent Wednesday after reporting a net loss that was bigger than expected.
Medical News Today
Study Finds Flu Vaccine Safe For Children With IBD
Main Category: Flu / Cold / SARS Also Included In: Pediatrics / Children's Health ; Crohn's / IBD Article Date: 08 May 2013 - 0:00 PDT Influenza immunization rates in children with inflammatory bowel disease are low despite its safety according to a new study by researchers at the Institute for Clinical Evaluative Sciences , Children's Hospital of ... (more)
Mon May 06, 2013
Flu vaccine safe for children with IBD, study shows
Influenza immunization rates in children with inflammatory bowel disease are low despite its safety according to a new study by researchers at the Institute for Clinical Evaluative Sciences , Children's Hospital of Eastern Ontario , the Ottawa Hospital Research Institute , and the University of Ottawa.
Sun May 05, 2013
Mucosal healing influences outcomes in ulcerative colitis treated with infliximab
Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab, reports this month's Alimentary Pharmacology & Therapeutics.